Chantix Update: The Good, the Bad and the Ugly
Jacksonville, OR: There has been much development on the Chantix portfolio in recent months that speaks to the Jekyll-and-Hyde personality of the smoking cessation drug introduced by Pfizer in 2006. Released amidst much fanfare and embraced by smokers trying to quit, Chantix was soon derailed by allegations of
Chantix suicide and Chantix lawsuits
[READ MORE]
Groupon Faces Class-Action Lawsuit
Chicago, IL: Groupon reportedly faces a class-action lawsuit alleging
securities fraud on the part of the company when it filed its IPO. The Groupon lawsuit, which has not been certified as a class action, joins other securities fraud litigation in allegations that companies committed stock option fraud or securities investment fraud by misleading investors
[READ MORE]
SEC Securities Fraud Investigation Nets Results
Washington, DC: The Securities and Exchange Commission (SEC) has brought the hammer down on a number of perpetrators in a
securities fraud case. The issue stems from an investigation that led to charges, in June of 2010, of securities fraud against three gentlemen from California and one from New Mexico
[READ MORE]